EventsThe 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S11. Formulation, Drug Delivery and Controlled Release of the event The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
29 Oct, 2025
Academic Editor
author-avatarGareth R. Williams
Citation
Habibu Tijjani, Oluremi A. Saliu, Oluwafemi A. Idowu, Ahmed Olatunde, Adegbenro Peter Adegunloye, Antioxidant and toxicological effects of verbenone enhanced with cyclodextrin and lysine in diclofenac induced oxidative stress mice, in Proceedings of The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Antioxidant and toxicological effects of verbenone enhanced with cyclodextrin and lysine in diclofenac induced oxidative stress mice

image
Oluremi A. Saliu 1
Ahmed Olatunde 2
1. Department of Environmental Health Science, Faculty of Health Sciences, National Open University of Nigeria, Abuja, Nigeria, Nigeria
2. Department of Medical Biochemistry, Abubakar Tafawa Balewa University, Bauchi, Nigeria, Nigeria
3. Department of Biochemistry, University of Ilorin, Ilorin, Nigeria, Nigeria
Abstract

Oxidative stress is a pathological condition that plays crucial roles in the pathogenesis of various diseases. This study evaluated the antioxidant and toxicological effects of verbenone enhanced with cyclodextrin and lysine in diclofenac induced oxidative stress mice. Adult Swiss mice (35) were randomly distributed into seven (7) groups, induced with oxidative stress and orally administered verbenone, lysine, cyclodextrin, verbenone-lysine, and verbenone-cyclodextrin at 200 mg/kg body weight for seven (7) days. Cyclodextrin treatment significantly increased (p<0.05) total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and triglycerides compared with diclofenac control. No significant alterations (p<0.05) were observed in very low density lipoprotein cholesterol (VLDL), while a significant increase (p<0.05) was observed with diclofenac treatment in liver triglycerides. No significant alterations (p<0.05) were observed with atherogenic index while cyclodextrin significantly increased cardiac index and coronary artery index. Plasma protein and catalase activities decreased significantly (p<0.05) in all treatment groups. No significant alterations (p<0.05) were observed in malondialdehyde and liver superoxide dismutase. Glutathione peroxidase activity decreased in plasma for verbenone, cyclodextrin, and verb-cyclodextrin, but increased in the liver with lysine and cyclodextrin treatments. Liver albumin and total bilirubin were elevated in treatments, while gamma-glutamyl transferase activity significantly increased (p<0.05) across all groups except with verbenone treatment. Histopathology revealed periportal inflammation in verb-lysine, and while liver and kidney architecture in verb-cyclodextrin and verbenone groups was preserved. The study reveals complex interactions between diclofenac-induced oxidative stress and the modulatory effects of verbenone, lysine, and cyclodextrin. Verbenone and the various mitigated oxidative damage, with cyclodextrin conjugation presented more safety profile compared to lysine conjugation. The combination of verbenone and lysine or cyclodextrin may provide valuable insights into the modulation of renal and hepatic functions under oxidative stress conditions.

Keywords
Antioxidant
Toxicological Effect
Verbenone
Cyclodextrin
Lysine
Oxidative Stress
Poster
Tijjani et al 20205.pdf
Pectin Films Containing Propranolol-Loaded Nanocapsules for Infantile Hemangioma Treatment
Efficient Delivery of Genetic Constructs to Uterine Fibroid Cells Using Peptide Nanocomplexes